Flovent
Product Images NDC 76519-1177

14 FDA label images from H.j. Harkins Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 76519-1177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (76519 1177 Ppac Label)

Label (76519 1177 Ppac Label)
Label for FLOVENT DISKUS 100 MCG by H.J. Harkins Company, Inc. Includes packaging details for a single unit of 60-dose inhaler. The label displays the NDC 76519-1177-00 and a caution statement about prescription dispensing. Also present are lot number, expiration date, compare information, and manufacturer code.*
FDA Label Image

Figurec (Figerc)

Figurec (Figerc)
Instructional illustration showing hands holding a FLOVENT DISKUS inhaler with an arrow indicating to slide the lever to the right to prepare a dose. The image demonstrates proper device operation for administering medication.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph comparing the percent change from baseline in FEV1 (forced expiratory volume in one second) over 12 weeks between FLOVENT DISKUS 100 mcg twice daily and placebo groups. The x-axis represents weeks from 0 to 12, and the y-axis shows percent change from baseline FEV1. FLOVENT DISKUS shows a higher and sustained increase in FEV1 compared to placebo throughout the study period.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line chart comparing the percentage change from baseline in FEV1 over 12 weeks between FLOVENT DISKUS 100 mcg twice daily and placebo groups. The x-axis represents the weeks (0 to 12) and the y-axis shows the percent change from baseline in FEV1. FLOVENT DISKUS shows a greater increase in FEV1 over time compared to the placebo.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line graph showing the percentage change from baseline in FEV1 over a 12-week period. Two groups are represented: FLOVENT DISKUS 250 mcg twice daily with baseline FEV1 of 2.44 L, and placebo with baseline FEV1 of 2.46 L. The FLOVENT DISKUS group shows a marked increase in FEV1 percentage change compared to the placebo group over the weeks.*
FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
A line graph comparing the percentage change from baseline in FEV1 over 12 weeks between FLOVENT DISKUS 500 mcg twice daily and placebo groups. The x-axis represents the weeks (0 to 12 and endpoint), and the y-axis shows the percentage change from baseline in FEV1. FLOVENT DISKUS data points are marked with squares, and placebo data points with diamonds, showing a higher increase for FLOVENT DISKUS over time.*
FDA Label Image

Figuera (Figurea)

Figuera (Figurea)
An instructional diagram of the FLOVENT DISKUS inhaler showing labeled parts: outer case, mouthpiece, lever, thumb grip, and counter. The label on the device indicates 60 blisters containing 100 mcg of fluticasone propionate inhalation powder, with spaces for pouch open and use by dates.*
FDA Label Image

Figureb (Figureb)

Figureb (Figureb)
An instructional illustration showing hands holding the FLOVENT DISKUS inhaler with an arrow indicating the direction to slide the lever. This demonstrates how to prepare the device for inhalation by sliding the lever outward.*
FDA Label Image

Figured (Figured)

Figured (Figured)
An instructional illustration showing a woman holding a FLOVENT DISKUS inhaler near her mouth, demonstrating how to use the inhaler device by exhaling and preparing to inhale medication.*
FDA Label Image

Figuree (Figuree)

Figuree (Figuree)
A black and white illustration showing a woman using a FLOVENT DISKUS inhaler. The woman is holding the inhaler to her mouth, demonstrating the proper technique for inhalation of the medication.*
FDA Label Image

Figuref (Figuref)

Figuref (Figuref)
Illustration showing two hands holding a FLOVENT DISKUS inhaler with an arrow indicating the direction to slide the device to prepare a dose for inhalation.*
FDA Label Image

Figureg (Figureg)

Figureg (Figureg)
An instructional grayscale illustration showing a woman with short hair standing at a sink, preparing to wash her hands. She is looking at the faucet, and a glass of water is placed on the counter beside the sink.*
FDA Label Image

Figureh (Figureh)

Figureh (Figureh)
Packaging label of FLOVENT DISKUS inhalation powder, containing fluticasone propionate 100 mcg per blister. The package indicates a count of 60 blisters with a total of 100 doses. The label includes instructions to punch open and use by a specified date. The product is labeled by H.J. Harkins Company, Inc.*
FDA Label Image

Image (Image)

Image (Image)
Chemical structure of the active ingredient for FLOVENT DISKUS by H.J. Harkins Company, Inc. The diagram shows a complex steroidal molecule typical of inhaled corticosteroids used in respiratory therapies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.